시장보고서
상품코드
2117034

반고형 제형 위탁생산 시장 : 제품별, 용도별, 종류별, 기업 규모별, 최종사용자별, 국가별, 지역별 - 세계 산업 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Semi-Solid Dosage Contract Manufacturing Market, By Product, By Application, By Type, By Company Size, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

발행일: | 리서치사: 구분자 AnalystView Market Insights | 페이지 정보: 영문 355 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




가격
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.
US $ 3,250 금액 안내 화살표 ₩ 4,538,000
PDF (5 User License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,560 금액 안내 화살표 ₩ 6,367,000
PDF & Excel (Enterprise User License) help
PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,650 금액 안내 화살표 ₩ 7,889,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

반고형 제형 위탁생산 시장 규모는 2025년에 209억 8,020만 달러로 평가되며, 2026년부터 2033년까지 CAGR 12.4%로 확대될 것으로 전망됩니다.

반고형 제형 위탁생산 시장에는 크림, 젤, 연고, 페이스트, 로션 및 기타 제제와 관련된 제제 개발, 공정 개선, 스케일업, GMP 준수 제조, 충전, 포장, 분석 시험 및 규제 대응을 포함한 아웃소싱 업무가 포함됩니다. 제조 공정에는 일반적으로 유화, 균질화, 분산, 유변학 제어, 탈기, 미생물학적 처리, 충전 공정이 포함되지만, 필요에 따라 무균 제조법이 채택되기도 합니다.

피부과 분야가 시장에서 가장 큰 점유율을 차지하고 있지만, 산부인과, 안과, 호르몬 제제, 기타 외용 치료제 등의 분야에서는 일반적으로 제제 개발 및 제조에 있어 더 높은 복잡성이 수반됩니다. FDA 보고서에 따르면, 2025년에는 689건의 ANDA(제네릭 의약품 승인 신청)가 승인되어 제네릭 의약품 제조에 대한 시장의 지속적인 관심이 드러났습니다. 전반적으로 시장에서는 위탁생산업체가 제공하는 제제 개발 역량, 규제 대응 지원, 공정 확장성 및 기타 상업적 측면에 주목하고 있습니다.

반고형 제형 위탁생산 시장 - 시장 역학

규제의 복잡성이 전문적인 제조 노하우에 대한 수요를 강화하고 있습니다

규제 요건으로 인해 이 분야의 전문 지식은 제형에 관한 전문성이 아웃소싱 결정의 중요한 기준이 되는 수준까지 높아지고 있습니다. 반고형 제형의 물리적 특성 외에도 점도, 입자 직경, 입도 분포, 함량 균일성, 물리적 및 미생물학적 안정성, 유효 성분의 방출과 같은 특성으로 인해 이러한 제형은 기술 이전의 관점에서 특히 과제를 안고 있습니다. 현재 각 스폰서사는 통합적인 접근 방식을 적용하여 제제 개발, 분석 평가, 검증, 임상용 배치 제조, 상업적 규모의 제조 및 규제 당국에 대한 신청을 관리할 수 있는 계약 개발 제조 기관(CDMO)을 찾고 있습니다. 2025년에 250건의 단순 신약 신청(ANDA)이 잠정 승인됨에 따라, FDA에서는 제네릭 의약품 개발이 크게 증가하고 있습니다. 이에 따라 CDMO 기업들은 현재 가장 복잡한 공정을 처리할 수 있는 역량을 최우선으로 삼고, 첨단 개발 및 분석 연구소, 규제 관련 전문 지식, 그리고 제네릭 의약품 및 브랜드 의약품을 시장에 출시해 온 풍부한 경험을 바탕으로 한 종단간(end-to-end) 서비스 제공에 주력하고 있습니다.

반고형 제형 위탁생산 시장 - 시장 세분화 분석:

세계 반고형 제형 위탁생산 시장은 제품, 용도, 종류, 기업 규모, 최종사용자 및 지역을 기준으로 세분화되어 있습니다.

제품별로는 크림이 여전히 가장 일반적인 제품 유형입니다. 그 이유는 크림 제형이 유효 성분, 적응증, 방출 속도 및 환자 선호도 측면에서 가장 큰 다양성을 제공하기 때문입니다. 혼합, 균질화, 온도 관리, 충전과 같은 확립된 공정을 통해 CDMO는 서로 다른 생산 계획에 따라 제네릭 의약품, 브랜드 의약품 또는 라이프사이클 프로그램의 생산 균형을 맞출 수 있습니다. 한편, 젤, 로션, 연고, 페이스트 및 이와 유사한 제형은 피부 침투성, 밀폐성, 특정 질감 또는 표적 작용이 가장 중요하게 요구되는 국소 투여 분야에서 여전히 수요가 있습니다. FDA는 2025년에 여드름 치료용 최초의 제네릭 타자로텐 로션을 승인했는데, 이는 국소용 의약품에 대한 지속적인 관심을 반영합니다. 그 결과, 제형에서 높은 범용성을 발휘하면서도 크림 제조에 대응할 수 있는 능력은 위탁생산업체에게 여전히 강점으로 작용하고 있습니다.

용도별로 보면 피부과 분야가 여전히 주요 용도이며, 반고형 제형의 고유한 특성을 가장 잘 활용하고 있습니다. 다양한 기제, 방출 메커니즘, 흡수율 및 사용 편의성을 통해 제조사는 적응증, 개별 환자의 요구, 투여 용이성 등 중요한 요건을 충족시킬 수 있습니다. 산부인과 및 호르몬 요법 분야에서도 외용 제제에 대한 관심이 높지만, 이러한 분야에서는 기제 선택, 투여량, 흡수 메커니즘 및 포장 옵션에 대해 더 엄격한 요건이 부과됩니다. 대조적으로, 점안액, 연고 및 이와 유사한 제제의 경우 더 높은 수준의 무균성과 이물질 및 오염 물질에 대한 관리가 요구되므로 제조사의 선택지가 제한됩니다. 외용제의 범용성을 보여주는 또 다른 예로, 2025년에 만성 손습진 치료제로 ‘안즈프고(Anzupgo) 크림’이 FDA 승인을 받은 것을 들 수 있습니다. 반고형 제형의 이점을 누릴 수 있는 적응증 범위가 넓다는 점은 제조사의 외주 패턴을 형성하고 있습니다. 피부과 분야에서 채택되는 표준적인 접근 방식에서는 더 높은 스케일업 능력이 요구되지만, 틈새 치료 분야에서는 무균 제조, 강화된 분석 지원 및 규제에 관한 전문 지식이 중시됩니다.

반고형 제형 위탁생산 시장 - 지역별 인사이트

북미는 확립된 제약 산업, 제네릭 의약품 생산에 대한 높은 의존도, 전문적인 CDMO 네트워크, 그리고 제형 개발자 및 규제 당국의 존재로 인해 반고형 제형 위탁생산 분야에서 여전히 중요한 지역으로 남아 있습니다. 이 지역에는 기술 이전 및 규제 준수 상업 생산 수요를 뒷받침하는 의약품 스폰서, 위탁생산업체, 분석 연구소 및 규제 전문가들이 모여 있습니다. FDA 보고서에 따르면, 2025 회계연도에 92건의 신규 제네릭 의약품 승인이 이루어졌으며, 이는 제네릭 의약품 프로그램에 대한 관심이 여전히 높음을 보여줍니다. 따라서 이 지역에서 사업을 전개하는 CDMO는 현지 시장 및 규제 환경에 크게 의존하고 있습니다. 북미는 제제 소유자 및 규제 승인 기관이 확립되어 있어 반고형 제형 위탁생산업체에게 있어 지배적인 지역이 되고 있습니다.

아시아태평양은 생산능력, 제형에 대한 전문 지식, 비용 효율적인 공정 개발, 그리고 수출 지향적인 제조 네트워크를 바탕으로 반고형 제형의 위탁생산 분야에서 부상하고 있는 지역입니다. 특히 인도의 경우, 현지 위탁생산 부문이 개발 기업 및 규제 당국에 엔드투엔드 서비스를 제공하고 있어 세계 의약품 공급망에서 그 역할이 확대되고 있습니다. 예를 들어, 레시팜(Recipharm)의 방갈로르 사업장에서는 반고형 제형 제조를 위한 개발, 임상 및 상업적 공급망을 지원하는 4개의 독립된 시설을 운영하고 있습니다. 따라서 이 지역은 인도의 강력한 제형 관련 전문 지식을 바탕으로, 여러 시장에 걸쳐 기술적 역할을 통합하고자 하는 제약사들을 끌어들이고 있습니다. 아시아태평양은 반고형 제형의 위탁생산 분야에서 기술 서비스 및 생산능력 면에서 다른 지역과 경쟁하고 있으며, 규제 준수 및 품질 관리를 특히 중시하고 있습니다.

목차

제1장 반고형 제형 위탁생산 시장 개요

제2장 주요 요약

제3장 반고형 제형 위탁생산 주요 시장 동향

제4장 반고형 제형 위탁생산 산업 분석

제5장 반고형 제형 위탁생산 시장 : 높아지는 지정학적 긴장의 영향

제6장 반고형 제형 위탁생산 시장 구도

제7장 반고형 제형 위탁생산 시장 : 제품별

제8장 반고형 제형 위탁생산 시장 : 용도별

제9장 반고형 제형 위탁생산 시장 : 유형별

제10장 반고형 제형 위탁생산 시장 : 기업 규모별

제11장 반고형 제형 위탁생산 시장 : 최종사용자별

제12장 반고형 제형 위탁생산 시장 : 지역별

제13장 주요 벤더 분석 : 반고형 제형 위탁생산 산업

제14장 AnalystView의 전방위 전망

KSM

Semi-Solid Dosage Contract Manufacturing Market size was valued at US$ 20,980.2 Million in 2025, expanding at a CAGR of 12.4% from 2026 to 2033.

The semi-solid dosage contract manufacturing market involves outsourcing activities, including formulation development, process refinement, scale-up, GMP production, filling, packaging, analytical tests, and regulatory support of creams, gels, ointments, pastes, lotions, and other formulations. Emulsifying, homogenizing, dispersing, controlling rheology, deairing, microbiological, and filling processes are usually involved in the production process, while the sterile method is used when necessary.

The dermatology category accounts for the largest share of the market, while areas such as gynecology, eye care, hormone-based drugs, and other topical treatments typically involve higher complexities in formulation and production. The FDA reports 689 ANDA approvals in 2025, showcasing the market's continuous interest in generic drug manufacturing. Overall, the market's focus is on the formulation capabilities, regulatory support, scalability of processes, and other commercial aspects offered by contract manufacturers.

Semi-Solid Dosage Contract Manufacturing Market- Market Dynamics

Regulatory Complexity Strengthens Demand for Specialized Manufacturing Expertise

Regulatory requirements are driving expertise in the field to a level that makes formulation expertise a key criterion for outsourcing decisions. The physical properties of semi-solid products, along with characteristics such as consistency, particle size, distribution, content uniformity, physical and microbiological stability, and the release of the active pharmaceutical ingredient, make these dosage forms particularly challenging in terms of technology transfer. Sponsors are now looking to contract development manufacturing organizations (CDMOs) that can manage formulation development, analytical assessment, validation, clinical-batch production, commercial-scale manufacturing, and regulatory filings by applying integrated approaches. With 250 tentative approvals of abbreviated new drug applications (ANDAs) in 2025, the FDA has seen a significant rise in generic drug development. Thus, CDMOs are now prioritizing the capability to handle the most complex processes and offer end-to-end services that leverage advanced development and analytical laboratories, regulatory expertise, and extensive experience in bringing generic and branded products to market.

Semi-Solid Dosage Contract Manufacturing Market- Segmentation Analysis:

The Global Semi-Solid Dosage Contract Manufacturing Market is segmented on the basis of Product, Application, Type, Company Size, End User, and Region.

By product, creams remain the most prevalent product type since their formulation offers the greatest degree of variability in terms of active ingredients, indication, release rate, and patient preferences. The well-established processes of mixing, homogenizing, temperature control, and filling allow CDMOs to balance the production of generic, brand, or lifecycle programs while following different production schemes. Meanwhile, gels, lotions, ointments, pastes, and similar formulations remain in demand for topical administration, where the need for skin penetration capacity, occlusivity, specific textures, or targeted action is most acute. The FDA approved the first generic tazarotene lotion in 2025 for the treatment of acne, reflecting the continuous interest in topical drugs. As a result, the ability to navigate cream production with high versatility in formulation remains an advantage for contract manufacturers.

By application, dermatology field remains the primary application as it benefits most from the unique attributes of semi-solid formulations. The variety of vehicles, release mechanisms, absorption rates, and convenience of use enables manufacturers to address the key requirements of indication, individual patient needs, and administration ease. While gynecology and hormone therapy are also interested in topical formulations, they impose more stringent requirements on the choice of vehicle, dosage, absorption mechanisms, and packaging options. In contrast, eye drops, ointments, and similar formulations require higher levels of sterility and control over foreign particles and contaminants, thus limiting the choice of manufacturers. Another illustration of topical drugs' versatility is the FDA approval of Anzupgo cream in 2025 for the treatment of chronic hand eczema. The range of applications that may benefit from semi-solid formulations shapes the outsourcing patterns of manufacturers; the standard approaches used in dermatology call for a higher ability to scale, while niche treatments value sterile production, enhanced analytical support, and regulatory expertise.

Semi-Solid Dosage Contract Manufacturing Market- Geographical Insights

North America remains a key region for semi-solid contract manufacturing due to its well-established pharmaceutical industry, heavy reliance on generic drug production, specialized CDMO networks, and presence of formulation developers and regulators. The region is home to drug sponsors, contract manufacturers, analytical laboratories, and regulatory experts that support the demand for technology transfer and compliant commercial production. According to FDA reports, there were 92 first-time generic approvals in fiscal year 2025, indicating the continuous interest in generic drug programs. Therefore, CDMOs that operate within the region are highly dependent on the local market and regulatory environment. North America is a dominant region for semi-solid contract manufacturers due to the established presence of formulation owners and regulatory approval centers.

Asia-Pacific is an emerging region for semi-solid contract manufacturing due to its production capabilities, formulation expertise, cost-effective process development, and export-oriented manufacturing networks. Notably, India is witnessing an increased role in the global pharmaceutical supply chain, as the local contract manufacturing sector provides end-to-end services for developers and regulators. Recipharm's Bengaluru site, for example, operates four separate facilities that support the development, clinical, and commercial supply chains for semi-solid production. Therefore, the region attracts manufacturers that seek to integrate their technical roles across multiple markets, supported by India's strong formulation expertise. The Asia-Pacific region competes against other regions in semi-solid contract manufacturing on technical services and production capabilities, with a strong emphasis on regulatory compliance and quality control.

Semi-Solid Dosage Contract Manufacturing Market- Competitive Landscape:

Competition in the semi-solid dosage contract manufacturing market is primarily driven by the replicability of formulations, analytical expertise, process validation, and the ability to transition products from development into commercial manufacturing. CDMOs offering unique expertise in rheology, formulation development, high potency, sterile production, packaging, regulatory know-how, and technology transfer capabilities are gaining an edge over others. Recipharm, for instance, reported in 2025 that it produced several hundred products for its customers in the pharma industry and across different dosage forms. Other key players, such as FAREVA, specialize in dosage forms and utilize their extensive networks of manufacturing sites around the globe to meet the needs of pharmaceutical companies. The trend in the contract manufacturing industry indicates that the competitive advantage is gained by offering end-to-end development to commercial platforms, validated processes, regulatory expertise, and reliable batch manufacturing.

Recent Developments:

In May 2025, FAREVA and Zhaoke Ophthalmology announced the opening of a manufacturing cooperation to support pharmaceutical production in China. The joint effort is dedicated to the development of eye care products both locally and with the possibility of outsourcing.

In September 2025, Recipharm launched its new corporate identity to unify the work on the development and manufacturing of generic and branded pharmaceuticals under one brand name. Thus, the company highlights its expertise in the field and commitment to continuous improvement in its services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Lonza Group Ltd.
  • Lubrizol Life Science
  • Bora Pharmaceuticals
  • Cambrex Corporation
  • Contract Pharmaceuticals Limited
  • Ascendia Pharmaceuticals
  • Piramal Pharma Solutions
  • DPT Laboratories, Ltd.
  • MedPharm Ltd.
  • Pierre Fabre Group
  • Catalent, Inc.
  • Almac Group
  • Recipharm AB
  • Aenova Group
  • Ajinomoto Bio-Pharma Services
  • ANI Pharmaceuticals, Inc.
  • Aurigene Pharmaceutical Services Limited
  • Douglas Pharmaceuticals Ltd.
  • Ferndale Pharma Group
  • Sterling Pharmaceutical Services LLC
  • Aphena Pharma Solutions Inc.
  • Fermion Oy
  • Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

  • Creams
  • Pastes
  • Gels
  • Lotions
  • Ointments
  • Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Gynecology
  • Dermatology
  • Ophthalmology
  • Hormonal therapy
  • Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY TYPE- MARKET ANALYSIS, 2020 - 2033

  • Transdermal
  • Topical
  • Oral

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY COMPANY SIZE- MARKET ANALYSIS, 2020 - 2033

  • Medium and Small-Size Companies
  • Large-Size Companies
  • Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Cosmeceutical Companies
  • Pharmaceutical Companies
  • Others

GLOBAL SEMI-SOLID DOSAGE CONTRACT MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Semi-Solid Dosage Contract Manufacturing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Semi-Solid Dosage Contract Manufacturing Key Market Trends

  • 3.1. Semi-Solid Dosage Contract Manufacturing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Semi-Solid Dosage Contract Manufacturing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Semi-Solid Dosage Contract Manufacturing Market Opportunities
  • 3.4. Semi-Solid Dosage Contract Manufacturing Market Future Trends

4. Semi-Solid Dosage Contract Manufacturing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Semi-Solid Dosage Contract Manufacturing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Semi-Solid Dosage Contract Manufacturing Market Landscape

  • 6.1. Semi-Solid Dosage Contract Manufacturing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Semi-Solid Dosage Contract Manufacturing Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2025 & 2033 (%)
    • 7.1.2. Creams
    • 7.1.3. Pastes
    • 7.1.4. Gels
    • 7.1.5. Lotions
    • 7.1.6. Ointments
    • 7.1.7. Others

8. Semi-Solid Dosage Contract Manufacturing Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Gynecology
    • 8.1.3. Dermatology
    • 8.1.4. Ophthalmology
    • 8.1.5. Hormonal therapy
    • 8.1.6. Others

9. Semi-Solid Dosage Contract Manufacturing Market - By Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 9.1.2. Transdermal
    • 9.1.3. Topical
    • 9.1.4. Oral

10. Semi-Solid Dosage Contract Manufacturing Market - By Company Size

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Company Size, 2025 & 2033 (%)
    • 10.1.2. Medium and Small-Size Companies
    • 10.1.3. Large-Size Companies
    • 10.1.4. Others

11. Semi-Solid Dosage Contract Manufacturing Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Cosmeceutical Companies
    • 11.1.3. Pharmaceutical Companies
    • 11.1.4. Others

12. Semi-Solid Dosage Contract Manufacturing Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Semi-Solid Dosage Contract Manufacturing Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Product, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By Company Size, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Semi-Solid Dosage Contract Manufacturing Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Lonza Group Ltd.
    • 13.2.2. Lubrizol Life Science
    • 13.2.3. Bora Pharmaceuticals
    • 13.2.4. Cambrex Corporation
    • 13.2.5. Contract Pharmaceuticals Limited
    • 13.2.6. Ascendia Pharmaceuticals
    • 13.2.7. Piramal Pharma Solutions
    • 13.2.8. DPT Laboratories, Ltd.
    • 13.2.9. MedPharm Ltd.
    • 13.2.10. Pierre Fabre Group
    • 13.2.11. Catalent, Inc.
    • 13.2.12. Almac Group
    • 13.2.13. Recipharm AB
    • 13.2.14. Aenova Group
    • 13.2.15. Ajinomoto Bio-Pharma Services
    • 13.2.16. ANI Pharmaceuticals, Inc.
    • 13.2.17. Aurigene Pharmaceutical Services Limited
    • 13.2.18. Douglas Pharmaceuticals Ltd.
    • 13.2.19. Ferndale Pharma Group
    • 13.2.20. Sterling Pharmaceutical Services LLC
    • 13.2.21. Aphena Pharma Solutions Inc.
    • 13.2.22. Fermion Oy
    • 13.2.23. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기